SAUDI ARABIA

Health official warns against unsupervised use of weight-loss drugs like Ozempic, Mounjaro

July 15, 2025

Saudi Gazette report

RIYADH — Saudi Deputy Minister of Health for Population Health, Dr. Abdullah Asiri, has issued a public warning against the unsupervised use of anti-obesity medications such as Ozempic and Mounjaro, emphasizing the serious health risks associated with misuse.

In a post on his official X account, Dr. Asiri cautioned that reckless reliance on these drugs or drastic dietary changes — such as extreme calorie restriction or rigid vegan diets — can result in nutritional imbalances that negatively affect overall health.

He noted that dietary supplements are generally unnecessary when one follows a well-balanced and complete diet.

He also advised the public to avoid foods high in fat and irritating spices, and to incorporate regular physical activity, such as walking and exercise, into their daily routines to maintain a healthy lifestyle without resorting to quick fixes or risky solutions.

His remarks come amid growing concern from medical professionals about the increasing popularity of weight-loss drugs being used without prescriptions, raising red flags over long-term safety and potential side effects.


July 15, 2025
3070 views
HIGHLIGHTS
SAUDI ARABIA
hour ago

Move to include new categories of individual workers under insurance coverage

SAUDI ARABIA
2 hours ago

SFDA shuts 54 erring firms and bans entry of 40 tons of contaminated poultry products

SAUDI ARABIA
3 hours ago

CEDA reviews report highlighting robust Saudi economic growth